3 Cancer Stocks to Watch in December

3 Cancer Stocks to Watch in December

Source: 
Motley Fool
snippet: 

The American Society of Hematology (ASH) begins its 60th annual meeting on Dec. 1, and this year's going to be one to remember. Acceleron Pharma Inc. (NASDAQ:XLRN)bluebird bio (NASDAQ:BLUE), and Amgen Inc. (NASDAQ:AMGN) are all scheduled to present highly anticipated results from experimental cancer therapies that could be worth billions. Here's what investors need to watch out for.